← Leaderboards
Thomas Rossetti
Weill Medical Coll Of Cornell Univ
$128,995
Attributed
$128,995
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$128,995 · 1
By mechanism
F31$128,995 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Timothy A Ryan$19,370,531
- Ashish Raj$11,940,644
- Leandro C Cerchietti$6,986,102
- Lawrence G Palmer$12,829,139
- Wen H. Shen$2,876,197
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAdenylate CyclaseBrain CellAge RelatedAge Related NeurodegenerationAging PopulationAlkalinityCell AgingAmyloidAutophagocytosisBaseBiologicalBiological SciencesBiologyAffectCell AgeAdenosine TriphosphateCell ModelCellsCell TypeCellular EngineeringCyclic AmpCyclizationAcids
Grant awards (3)
Activation of Soluble Adenylyl Cyclase as a Novel Therapeutic Strategy for the Treatment of Age-Related Neurodegenerative Disorders$37,439
F31 · FY2022 · AG · contact PI
Activation of Soluble Adenylyl Cyclase as a Novel Therapeutic Strategy for the Treatment of Age-Related Neurodegenerative Disorders$46,036
F31 · FY2021 · AG · contact PI
Activation of Soluble Adenylyl Cyclase as a Novel Therapeutic Strategy for the Treatment of Age-Related Neurodegenerative Disorders$45,520
F31 · FY2020 · AG · contact PI